Increasing blood flow to tissue with angiogenic material containing polymer and vascularizing compound

• US 6,641,832 B2
• Filed: 12/20/2000
• Issued: 11/04/2003
• Est. Priority Date: 10/31/1995
• Status: Expired due to Fees

• Current Assignee: Julia Elizabeth Babensee, Michael Humphrey May, Michael Vivian Sefton
• Original Assignee: Julia Elizabeth Babensee, Michael Humphrey May, Michael Vivian Sefton
• Inventors: Sefton, Michael Vivian, Babensee, Julia Elizabeth, May, Michael Humphrey
• Primary Examiner(s): Naff, David M.
• Application Number:
  US09/739,662
• Publication Number:
  US 20020037308A1
• Time in Patent Office: 1,049 Days
• Field of Search: 435/174, 435/177, 435/180, 435/182, 435/382, 435/395, 424/422, 424/423, 424/443, 424/445, 424/486, 424/489, 424/501, 424/93.7, 424/78.08, 424/78.31
• US Class Current: 424/423
• CPC Class Codes: A61K 9/5089 Processes

Abstract

An angiogenic material is prepared which promotes extensive vascularization when implanted in animal tissue. The angiogenic material is preferably used in microcapsule coatings and microspheres for implantation in animals. In microcapsules, the angiogenic material promotes better exchange of nutrients, waste products and cellular products between encapsulated cells and the circulatory system of the host animal. Preferably, the angiogenic material consists of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions. Microspheres containing the angiogenic material may be used to assist in recovery of ischemic heart muscle by injection of the microspheres into the heart muscle or blood vessels serving the ischemic area. Also disclosed is a method of forming small microcapsules and microspheres by passing cell aggregates or air bubbles through layers of a density gradient.

Claims

1. A method for increasing blood flow in the vicinity of a wound consisting of bed sores, venous ulcers, diabetic ulcers or burn wounds comprising:

applying micro spheres consisting of an angiogenic material to the surface of the wound,

said angiogenic material consisting of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions and which promote the growth of blood vessels, which, when implanted in animal tissue, said angiogenic material promotes generation of blood vessels in its immediate vicinity and induces minimal or no fibrous capsule formation.

2. A method as claimed in claim 1 further comprising, before applying said microspheres to the surface of said wound, incorporating said microspheres into a wound care product consisting of wet dressings, dry dressings, occlusive dressings, non-occlusive dressings or wound pastes.

3. A method as claimed in claim 2, wherein said vascularizing compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

4. A method as claimed in claim 2, wherein said vascularizing compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

5. A method as claimed in claim 2, wherein said biocompatible polymer consists of polyacrylates.

6. A method as claimed in claim 2, wherein said vascularizing compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.

7. A method as claimed in claim 1, wherein said vascularizing compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

8. A method as claimed in claim 1, wherein said vascularizing compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

9. A method as claimed in claim 1, wherein said biocompatible polymer consists of polyacrylates.

10. A method as claimed in claim 1, wherein said vascularizing compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.

11. A method for increasing blood flow to transplanted cadaverous gum tissue comprising:

positioning microspheres consisting of an angiogenic material between the transplanted tissue and a host tissue along a suture line,

said angiogenic material consisting of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions and which promote the growth of blood vessels, which, when implanted in animal tissue, said angiogenic material promotes generation of blood vessels in its immediate vicinity and induces minimal or no fibrous capsule formation.

12. A method as claimed in claim 11, wherein said vascularizing compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

13. A method as claimed in claim 11, wherein said vascularizing compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

14. A method as claimed in claim 11, wherein said biocompatible polymer consists of polyacrylates.

15. A method as claimed in claim 11, wherein said vascularizing compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.

16. A method of increasing blood flow in the vicinity of a wound consisting of bed sores, venous ulcers, diabetic ulcers or bum wounds comprising:

applying an angiogenic material to the surface of the wound,

said angiogenic material consisting of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions and which promote the growth of blood vessels, which, when implanted in animal tissue, said angiogenic material promotes generation of blood vessels in its immediate vicinity and induces minimal or no fibrous capsule formation.

17. A method as claimed in claim 16, wherein said vascularizing compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

18. A method as claimed in claim 16, wherein said vascularizing compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

19. A method as claimed in claim 16, wherein said biocompatible polymer consists of polyacrylates.

20. A method as claimed in claim 16, wherein said vascularizing compound consists of methacrylic acid which is incorporated into the biocamptible polymer at the time of polymerization.

21. A method as claimed in claim 16, further comprising, before applying said angiogenic material to the surface of said wound, incorporating said angiogenic material into a wound care product consisting of wet dressings, dry dressings, occlusive dressings, non-occlusive dressings or wound pastes.

22. A method as claimed in claim 21, wherein said vascularizing compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

23. A method as claimed in claim 21, wherein said vascularizing compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

24. A method as claimed in claim 21, wherein said biocompatible polymer consists of polyacrylates.

25. A method as claimed in claim 21, wherein said vascularizing compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.

26. A method for increasing blood flow to transplanted cadaverous gum tissue comprising:

positioning an angiogenic material between the transplanted tissue and a host tissue along a suture line,

said angiogenic material consisting of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions and which promote the growth of blood vessels, which, when implanted in animal tissue, said angiogenic material promotes generation of blood vessels in its immediate vicinity and induces minimal or no fibrous capsule formations.

27. A method as claimed in claim 26 wherein said vascularizing compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

28. A method as claimed in claim 26, wherein said vascularizing compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

29. A method as claimed in claim 26, wherein said biocompatible polymer consists of polyacrylates.

30. A method as claimed in claim 26, wherein said vascularizing compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.